Jump to navigation

  • IHME
  • GHDx
  • GBD Compare
Home
Main menu
  • Home
  • Results
    • GBD Results Tool
    • Data Visualizations
    • Country Profiles
    • GBD 2019 Cause and Risk Summaries
    • US Health
    • Policy Reports
    • Research Articles
    • Infographics
    • Topics
    • Data & Tools
  • News & Events
    • News
    • Commentaries
    • Events
    • Videos
    • Acting on Data
      • IHME Foundations
  • Projects
    • COVID-19 resources
    • Global Burden of Disease (GBD)
    • Center for Health Trends and Forecasts (CHTF)
    • Disease Control Priorities Network (DCPN)
    • View all
  • Get Involved
    • Donate
    • Careers
    • Call for Collaborators
    • The Roux Prize
    • Online Training
    • Workshops
  • About
    • Our Principles
    • Racism is a public health issue.
    • Senior Management Team
    • Faculty
    • Governance
    • History
    • GHDx
    • Terms and Conditions
    • Contact Us

Explore section

News & Events

  • News
  • Commentaries
  • Events
  • Videos
  • Acting on Data
    • IHME Foundations

COVID-19 Modeling | One Year Later: Questions Remain (ASL)


Twitter
Facebook
Google+
LinkedIn
Pinterest
Email
Print
Publication date: 
March 26, 2021

 

 

Chris Murray addresses how much there is still yet to learn about COVID-19.

Transcription: I think the most important thing we’ve learned is the critical importance of thinking about who the users are of our forecasts, because we're trying to help people make hard choices and that’s both hospital systems, which is what we started with, in terms of planning but also policymakers, who we now interact with extensively, who are looking farther ahead, several months or even longer, and wanting to figure out what are the main strategies they need to pursue. Is it social distancing mandates? Is it scaling up vaccination faster? What are the types of strategies they should use around travel? Many, many questions that come up in the course of modeling. I think we have learnt that it’s super important to listen to the people we’re trying to help, and building in the sort of things they want to hear and understand, into how we go about modeling.

Last but certainly not least is the recognition that we still have many, many questions about COVID that we just don't understand. Why has the epidemic not been larger in south Asia or sub-Saharan Africa so far? Why has there been a very small epidemic in Uruguay, when Argentina and southern Brazil have had large epidemics? You could make a very long list of these COVID mysteries. And the fact there are so many should make us humble about thinking that we really fully understand the epidemic. And it's also why we think it's so important to keep abreast of what's happening, and keep revising what we do, and update the models both with data and improvements on the models, on a weekly basis. 

Related Content

Videos

COVID-19 Modeling | One Year Later: Questions Remain

Chris Murray addresses how much there is still yet to learn about COVID-19.

Projects

COVID-19 resources
IHME’s COVID-19 projections were developed in response to requests from the University of Washington School of Medicine and other US hospital systems and state...

News & Events

  • News
  • Commentaries
  • Events
  • Videos
  • Acting on Data
    • IHME Foundations

Sign up for IHME News

Stay connected

     

IHME

Institute for Health Metrics and Evaluation

Population Health Building/Hans Rosling Center

3980 15th Ave. NE, Seattle, WA 98195

UW Campus Box #351615

Tel: +1-206-897-2800

Fax: +1-206-897-2899

© 2020 University of Washington

  • Privacy policy
  • Login

  • Home
  • Results
    • GBD Results Tool
    • Data Visualizations
    • Country Profiles
    • GBD 2019 Cause and Risk Summaries
    • US Health
    • Policy Reports
    • Research Articles
    • Infographics
    • Topics
    • Data & Tools
  • News & Events
    • News
    • Commentaries
    • Events
    • Videos
    • Acting on Data
  • Projects
    • COVID-19 resources
    • Global Burden of Disease (GBD)
    • Center for Health Trends and Forecasts (CHTF)
    • Disease Control Priorities Network (DCPN)
    • View all
  • Get Involved
    • Donate
    • Careers
    • Call for Collaborators
    • The Roux Prize
    • Online Training
    • Workshops
  • About
    • Our Principles
    • Racism is a public health issue.
    • Senior Management Team
    • Faculty
    • Governance
    • History
    • GHDx
    • Terms and Conditions
    • Contact Us

Projects

  • Global Burden of Disease (GBD)
  • Disease Control Priorities Network (DCPN)
  • ABCE+: A Focus on Antiretroviral Therapy (ART)
  • Access, Bottlenecks, Costs, and Equity (ABCE)
  • Efficacy to Effectiveness
  • Viral Load Pilot
  • Salud Mesoamérica Initiative
  • Improving Methods to Measure Comparable Mortality by Cause
  • Verbal Autopsy (VA)
  • Disease Expenditure (DEX)
  • State-level disease burden initiative in India
  • US Counties Drivers of Health Study
  • University of Washington Center for Health Trends and Forecasts